Maverick Capital’s Chemours CC Stock Holding History

Maverick Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,993	Closed	-$289K	–	299
2024 Q1	$289K	Buy	+10,993	New	+$313K	0.01%	353
2022 Q1	–	Sell	-3,624	Closed	-$122K	–	257
2021 Q4	$122K	Sell	3,624 -30,668	-89%	-$955K	﹤0.01%	162
2021 Q3	$997K	Buy	34,292 +28,410	+483%	+$920K	0.01%	316
2021 Q2	$205K	Sell	5,882 -1,710	-23%	-$56.6K	﹤0.01%	484
2021 Q1	$212K	Buy	+7,592	New	+$202K	﹤0.01%	489
2018 Q1	–	Sell	-102,860	Closed	-$5.15M	–	229
2017 Q4	$5.15M	Buy	102,860 +42,650	+71%	+$2.23M	0.07%	154
2017 Q3	$3.05M	Sell	60,210 -3,670	-6%	-$173K	0.04%	144
2017 Q2	$2.42M	Sell	63,880 -20,030	-24%	-$790K	0.03%	118
2017 Q1	$3.23M	Sell	83,910 -49,500	-37%	-$1.49M	0.04%	35
2016 Q4	$2.95M	Buy	+133,410	New	+$2.74M	0.04%	83

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Maverick Capital's CC Position: Q2 2024 in Review

Maverick Capital sold out of Chemours (CC) in Q2 2024, closing a stake of 10,993 shares — an estimated $289K sold.

Maverick Capital first reported a position in CC in Q4 2016 and held it in 10 quarters. The position peaked at $5.15M in Q4 2017. 435 funds tracked by Wall St. Rank hold CC as of Q2 2024.

Maverick Capital reported no remaining Chemours position as of Q2 2024 after selling out during the quarter.
Maverick Capital sold 10,993 Chemours shares in Q2 2024, an estimated $289K.
Maverick Capital first reported a position in Chemours in Q4 2016 and held it in 10 quarters.
Maverick Capital's Chemours position peaked at $5.15M in Q4 2017.
435 funds tracked by Wall St. Rank held Chemours as of Q2 2024.

Based on Maverick Capital's 13F filing for Q2 2024, filed 14 Aug 2024.